Pharmacy
Sanofi-Aventis:New study provides additional information about an intensified dose-regimen of plavix
The FINANCIAL -- On August 30, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical trial...
Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban (ROCKET AF)
The FINANCIAL -- Bayer Schering Pharma has completed patient enrollment into the Phase III ROCKET AF study (Rivaroxaban Once daily oral...
UCB and Novartis to expand cooperation in Germany
The FINANCIAL -- UCB and Novartis announced on August 24 that they entered into a licensing agreement for cardiovascular and diabetes products...
Novartis receives approval in EU for Xolair to treat children age 6 to 11 years suffering from alle
The FINANCIAL -- Novartis announced on August 24 that the European Commission (EC) has approved Xolair (omalizumab) as add-on therapy...
Novartis unveils Lab of Future concept to top European students at Biotechnology Leadership Camp
The FINANCIAL -- On August 24, Novartis highlighted its ongoing commitment to fostering research and innovation at the 2009 Novartis...
Solvay welcomes FDA approval for Trilipix
The FINANCIAL -- Solvay’s and Abbott's TriLipix TM (fenofibric acid delayed-release capsules) was approved by the U.S. Food and Drug...
US FDA approves Extavia – the first in a new portfolio of planned MS therapies
The FINANCIAL -- The US Food and Drug Administration (FDA) has approved Extavia (interferon beta-1b), the first in a new...
Nycomed and Forest Laboratories to collaborate on US commercialisation of Daxas in COPD
The FINANCIAL -- Nycomed and Forest Laboratories, Inc. (NYSE: FRX) on August 10 announced that they have entered into an exclusive development,...
Zogenix,Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel DosePro
The FINANCIAL -- Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical company and Astellas Pharma US, Inc. (“Astellas”), announced on August...
Nycomed to acquire local portfolio from Sanofi-Aventis and Zentiva
The FINANCIAL -- Nycomed agreed with Sanofi-Aventis and Zentiva to purchase 20 branded generic products in several Central and Eastern...
Avastin approved in US for the most common type of kidney cancer
The FINANCIAL -- Roche on August 3 announced that the U.S. Food and Drug Administration (FDA) has approved Avastin (bevacizumab) plus interferon alpha...
Shire Saw Positive Results From Gaucher Drug Trial
The FINANCIAL -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, on August 3 reported positive results from the...
Takeda Submits a New Drug Application for a Fixed-Dose Combination Tablet of Actos with sulfonylurea
The FINANCIAL -- Takeda Pharmaceutical Company Limited ("Takeda") announced on July 27 that it filed a New Drug Application to the Ministry...
Agreements Concluded for “SELTOUCH Pap 70, 140”
The FINANCIAL -- Wyeth K.K. (Headquarters: Shinagawa-ku, Tokyo, President & Representative Director Michael Goettler, “WKK”), ASKA Pharmaceutical Co., Ltd (Headquarters:...
Nycomed announces FDA filing for Daxas in COPD
The FINANCIAL -- Nycomed on July 20 announced the submission of a New Drug Application (NDA) to the US Food and Drug...
ADVERTISEMENT
Popular Last 24h
-
Justice Department Files Voting Rights Suit Against City of Hazleton, Pennsylvania
-
Ampersand wins £22m five-year contract at London Zoo
-
Minnesota Man Sentenced To 15 Months For Trafficking In Stolen Human Remains
-
How the Aging Brain Affects Thinking
-
ICE Acquires the American Financial Exchange (AFX)
-
Chinese National Arrested for Selling Equipment Used to Manufacture Counterfeit Pills
-
Zebra dies after ‘incident’with rhino at zoo
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
